Trials begin of surgical glue for brain surgery:
This article was originally published in Clinica
Executive Summary
The first patients have been treated with a new type of surgical sealant for preventing cerebrospinal fluid (CSF) leaks during brain surgery. Trials of the glue, called FocalSeal-S and made by US firm Focal, are being conducted at three university medical centres in Switzerland, the Netherlands and France. CSF leaks can cause meningitis and other infections as well as debilitating headaches as the brain settles onto the spinal column after CSF is lost. Lexington, Massachusetts-based Focal said over one million head and spinal surgeries are performed each year.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.